GRDN
Guardian Pharmacy·NYSE
--
--(--)
--
--(--)
5.45 / 10
Netural
Fundamental analysis reveals a mixed picture: positive cash-flow and revenue metrics contrast with declining net-income trends. Key strengths include Cash-MV (score 2) and Revenue-MV (score 3), while Net income-Revenue shows weakness (score 0). This balance supports cautious accumulation rather than aggressive buying.
Analysis Checks(6/10)
Revenue-MV
Value0.56
Score3/3
Weight42.43%
1M Return9.68%
Value0.56
Score3/3
Weight42.43%
1M Return9.68%
Net income-Revenue
Value-1.67
Score0/3
Weight-0.72%
1M Return-0.21%
Value-1.67
Score0/3
Weight-0.72%
1M Return-0.21%
Total profit (YoY growth rate %)
Value151.18
Score2/3
Weight7.65%
1M Return2.01%
Value151.18
Score2/3
Weight7.65%
1M Return2.01%
Diluted earnings per share (YoY growth rate %)
Value122.50
Score1/3
Weight2.02%
1M Return0.52%
Value122.50
Score1/3
Weight2.02%
1M Return0.52%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value123.20
Score3/3
Weight15.81%
1M Return4.09%
Value123.20
Score3/3
Weight15.81%
1M Return4.09%
Net cash flow from operating activities per share (YoY growth rate %)
Value84.23
Score2/3
Weight5.11%
1M Return1.41%
Value84.23
Score2/3
Weight5.11%
1M Return1.41%
Basic earnings per share (YoY growth rate %)
Value123.00
Score1/3
Weight2.19%
1M Return0.58%
Value123.00
Score1/3
Weight2.19%
1M Return0.58%
Net cash flow from operating activities (YoY growth rate %)
Value84.31
Score2/3
Weight10.28%
1M Return2.70%
Value84.31
Score2/3
Weight10.28%
1M Return2.70%
Asset-MV
Value-0.50
Score1/3
Weight6.46%
1M Return1.95%
Value-0.50
Score1/3
Weight6.46%
1M Return1.95%
Cash-MV
Value-0.58
Score2/3
Weight8.77%
1M Return2.59%
Value-0.58
Score2/3
Weight8.77%
1M Return2.59%
Revenue-MV
Value0.56
Score3/3
Weight42.43%
1M Return9.68%
Value0.56
Score3/3
Weight42.43%
1M Return9.68%
Net cash flow from operating activities per share (YoY growth rate %)
Value84.23
Score2/3
Weight5.11%
1M Return1.41%
Value84.23
Score2/3
Weight5.11%
1M Return1.41%
Net income-Revenue
Value-1.67
Score0/3
Weight-0.72%
1M Return-0.21%
Value-1.67
Score0/3
Weight-0.72%
1M Return-0.21%
Basic earnings per share (YoY growth rate %)
Value123.00
Score1/3
Weight2.19%
1M Return0.58%
Value123.00
Score1/3
Weight2.19%
1M Return0.58%
Total profit (YoY growth rate %)
Value151.18
Score2/3
Weight7.65%
1M Return2.01%
Value151.18
Score2/3
Weight7.65%
1M Return2.01%
Net cash flow from operating activities (YoY growth rate %)
Value84.31
Score2/3
Weight10.28%
1M Return2.70%
Value84.31
Score2/3
Weight10.28%
1M Return2.70%
Diluted earnings per share (YoY growth rate %)
Value122.50
Score1/3
Weight2.02%
1M Return0.52%
Value122.50
Score1/3
Weight2.02%
1M Return0.52%
Asset-MV
Value-0.50
Score1/3
Weight6.46%
1M Return1.95%
Value-0.50
Score1/3
Weight6.46%
1M Return1.95%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value123.20
Score3/3
Weight15.81%
1M Return4.09%
Value123.20
Score3/3
Weight15.81%
1M Return4.09%
Cash-MV
Value-0.58
Score2/3
Weight8.77%
1M Return2.59%
Value-0.58
Score2/3
Weight8.77%
1M Return2.59%
Is GRDN undervalued or overvalued?
- GRDN scores 5.45/10 on fundamentals and holds a Fair valuation at present. Backed by its 16.38% ROE, 2.84% net margin, 53.31 P/E ratio, 10.97 P/B ratio, and 0.00% earnings growth, these metrics solidify its Netural investment rating.
